|
|
Idorsia Ltd
SIX •
Healthcare •
Biotechnology •
Quote as of 05/18/2026 17:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization1,169.08 mln
Float155 mln
Earnings Date04/28/2026
Key Fundamentals
EPS-1.03
RPS0.96
ROIC-26.86
ROA-46.82
EBITDA, mln-50.35
EV / EBITDA-47.16
EV / EBIT-34.09
Revenue, mln219
EV / Revenue9.74
Financial Strength
Altman Z-Score-10.03
Piotroski F-Score
4
/ 9
Beneish M-Score-1.54
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
7.71% |
98
/ 100
 |
| 1 Month |
14.17% |
94
/ 100
 |
| 2 Months |
19.37% |
92
/ 100
 |
| 6 Months |
33.02% |
91
/ 100
 |
| 1 Year |
220% |
100
/ 100
 |
|
| |